Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.23.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Revenue $ 4,122 $ 2,567
Cost of revenue 2,122 1,358
Gross profit 2,000 1,209
Operating expenses:    
Sales and marketing 2,088 1,629
Research and development 1,154 921
General and administrative 3,206 2,896
Total operating expenses 6,448 5,446
Loss from operations (4,448) (4,237)
Other (expense) income, net:    
Interest expense (127) (27)
Loss on revaluation of warrant liabilities (26) (100)
Unrealized gain (loss) on foreign exchange 217 (254)
Other expense, net (5) (2)
Total other income (expense), net 59 (383)
Net loss (4,389) (4,620)
Other comprehensive (loss) income (194) 212
Comprehensive loss $ (4,583) $ (4,408)
Net loss per share applicable to common shareholders, basic (in dollars per share) $ (0.33) $ (0.36)
Net loss per share applicable to common shareholders, diluted (in dollars per share) $ (0.33) $ (0.36)
Weighted average number of shares outstanding, basic (in shares) 13,296 12,728
Weighted average number of shares outstanding, diluted (in shares) 13,296 12,728